-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Patiromer Sorbitex Calcium in Resistant Hypertension
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Patiromer Sorbitex Calcium in Resistant HypertensionDrug Details:Patiromer sorbitex calcium (RLY5016, Veltassa) is a cross-linked polymer of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sodium Zirconium Cyclosilicate in Chronic Kidney Disease (Chronic Renal Failure)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sodium Zirconium Cyclosilicate in Chronic Kidney Disease (Chronic Renal Failure) Drug Details: Sodium zirconium...
-
Product Insights
Clinical Decision Support Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Clinical Decision Support Systems Pipeline Market Report Overview The Clinical Decision Support Systems (CDSS) are software tools that assist healthcare professionals with decision-making. The software consolidates a medical knowledge base with patient information to produce case-specific advice. The Clinical Decision Support Systems pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the...
-
Company Profile
Ardelyx Inc – Company Profile
Ardelyx Inc (Ardelyx), is a pharmaceutical company. It is a developer of small molecule therapeutics for treatment of cardio-renal, gastrointestinal and metabolic disorders. The company offers products that include tenapanor, and RDX013. Its products are used for hyperphosphatemia in patients with end-stage renal disease, constipation-predominant irritable bowel syndrome, and hyperkalemia, in chronic kidney disease patients. Ardelyx develops proprietary drug discovery and design platform to discover and design novel drug candidates such as tenapanor and others. The company works in partnership...
Add to Basket -
Company Profile
NewTorii Pharmaceutical Co Ltd – Company Profile
Torii Pharmaceutical Co Ltd (Torii Pharma), a subsidiary of Japan Tobacco Inc, manufactures and markets pharmaceuticals for the treatment of renal diseases, skin diseases and allergies. The company’s marketed portfolio spans topical corticosteroids, therapeutic agents for hyperphosphatemia, oral therapeutic agents for pruritus and therapeutic agents for hyperkalemia. It also offers Japanese cedar pollen sublingual drops, Japanese cedar pollen sublingual tablets, and house dust mite sublingual tablets for the treatment of various allergies. Torii Pharma markets its products through its network...
Add to Basket -
Company Profile
NewVifor Pharma Management Ltd – Company Profile
Vifor Pharma Management Ltd (CSL Vifor) formerly Galenica Ltd, focuses on discovery, development, and marketing of prescription medicines and non-prescription drugs. The company offers intravenous pharmaceuticals for iron deficiency, besides products for nephrology and cardio-renal therapies. It also provides pharmaceuticals for the treatment of respiratory tract infections, ear care, abdominal distension, chronic obstructive pulmonary disease, hemorrhoids, chronic venous insufficiency, diabetic retinopathy, lower urinary tract infections, menometrorrhagia, chronic kidney disease, and hyperkalemia. Vifor Pharma also discovers, develops, and markets polymeric medicines...
Add to Basket -
Product Insights
Net Present Value Model: Veltassa
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Veltassa Drug Details Patiromer sorbitex calcium...
-
Product Insights
Net Present Value Model: Lokelma
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Lokelma Drug Details Sodium zirconium cyclosilicate...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – RDX-013
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry RDX-013 Drug Details RDX-013 is under development for the treatment of hyperkalemia in patients...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – sodium zirconium cyclosilicate
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry sodium zirconium cyclosilicate Drug Details Sodium zirconium cyclosilicate (Lokelma) is a selective oral sorbent....